Veonet

What Veonet does

Veonet GmbH is a Munich-headquartered ophthalmology group operating a network of eye care clinics across Europe. The company provides a full spectrum of ophthalmology services — cataract surgery, glaucoma treatment, retinal care, and paediatric ophthalmology — delivered through physical clinic locations on a direct-to-consumer basis. Veonet reports 2.5 million consultations and 0.7 million procedures annually, making it one of the largest dedicated ophthalmology platforms in Europe by patient throughput. The company expanded significantly in 2022 with the acquisition of Miranza, a leading Spanish ophthalmology clinic group, in a transaction valued at more than €250 million, giving Veonet a multi-country footprint spanning Germany, Spain, and (as of 2025) the Republic of Ireland.

Veonet's core technology stack centers on clinical ophthalmology delivery augmented by digitalisation initiatives, most notably RetinSight AI for digital retinal imaging analysis. The platform supports a multi-specialty clinical model with a Medical Board, research and innovation programs, and active participation in international congresses such as ESCRS 2024. Revenue is generated per-procedure and per-consultation (professional-services model) with quote-based pricing; the group employs between 1,001 and 5,000 people across its European operations.

The business is led by Group CEO Sebastian James, who joined in mid-2024 from a senior role at Boots, with Judith Barth serving as Group CFO. Veonet is privately held with no public listing, and ownership beyond the historical Magnum Industrial Partners stake in Miranza is not publicly disclosed. Recent strategic emphasis has been on geographic expansion (Ireland greenfield), AI-enabled diagnostic capability, and integration of the Miranza platform across European markets.

Name

Veonet

Legal name

Veonet GmbH

Website

https://veonet-group.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Veonet is a Munich-based ophthalmology group operating a multi-country network of eye care clinics in Europe, delivering cataract, glaucoma, retinal, and pediatric services to patients on a direct-to-consumer basis with 2.5 million annual consultations.

Ownership category

akta.pro rank

Product category

Ophthalmology Healthcare Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Offices of Optometrists (621320), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC)

akta.pro secondary industries

Ophthalmology Surgery Centers (HLAFAIAF), Retina & Vitreous Specialists (HLAKAKAE), Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)

Keywords

• Ophthalmology services
• Eye care clinics
• Cataract surgery
• Retinal treatment
• Vision care

Headquarters

HQ city

München

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Ophthalmology Healthcare Services: Revenue generated from providing eye care services including cataract surgery, glaucoma treatment, retinal care, and paediatric ophthalmology. Services are delivered through clinic-based consultations and procedures.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Veonet operates a Europe-wide network of eye care clinics providing a full spectrum of ophthalmology services to individual patients, including cataract surgery, glaucoma treatment, retinal care, and paediatric ophthalmology. The group delivers over 2.5 million consultations and 0.7 million surgical and treatment procedures per year through its clinic-based model, and supports clinical practice with AI-assisted diagnostic technology such as RetinSight AI.

Product overview

Veonet is Europe’s leading ophthalmology group providing a unified, full-spectrum eye care platform offering cataract surgery, glaucoma treatment, retinal care, and paediatric ophthalmology services. The company integrates advanced technology and clinical expertise across its markets, delivering over 2.5 million consultations and 0.7 million procedures annually through its network of clinics. The four named services represent the core clinical offerings within Veonet's single integrated healthcare delivery platform, which operates across multiple European countries including Germany, Spain (via the acquired Miranza group), and the Republic of Ireland.

Differentiator

Problem solved

Functional benefit

Products and services

• Cataract Surgery Surgical procedure to remove and replace the natural lens of the eye that has become clouded, restoring clear vision for patients.
• Glaucoma Treatment Medical and surgical interventions to manage intraocular pressure and prevent optic nerve damage leading to vision loss.
• Retinal Care Specialized diagnostics and treatments for conditions affecting the retina, including diabetic retinopathy, macular degeneration, and retinal detachment.
• Paediatric Ophthalmology Eye care services specialized for children, addressing developmental vision issues, strabismus, amblyopia, and other pediatric eye conditions.

Quantifiable outcome

• 2.5 million consultations per year
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• MiranzacoreStrategic or Co-development Partner · 13 September 2022Veonet acquired Miranza, a leading ophthalmology clinic group in Spain, in a transaction valued at more than €250 million. The acquisition includes continuity of all existing Miranza staff and operations. This acquisition significantly expanded Veonet's presence in the Spanish market.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Carl Zeiss Meditec: Global leader in ophthalmic diagnostic and surgical devices (slit lamps, OCT, surgical microscopes) — broader incumbent in ophthalmology whose installed equipment base is the platform Veonet's RetinSight AI often integrates with.
• Alcon: Global ophthalmic medical device and pharmaceutical company providing IOLs, surgical equipment, and pharmaceuticals — broader incumbent whose products are used inside Veonet's surgical theatres.
• Moorfields Eye Hospital NHS Foundation Trust: One of the world's oldest and largest dedicated ophthalmic hospitals, offering comprehensive medical and surgical eye care — broader incumbent in specialty ophthalmic hospital services overlapping Veonet's clinical scope.
• Bausch + Lomb: Global ophthalmic device, pharmaceutical, and consumer eye-health company — broader incumbent with overlapping surgical and vision-care product portfolio.

Direct peers

• Optimax: UK-based laser eye surgery and lens replacement clinic chain — comparable consumer-direct ophthalmology services operator with a multi-clinic footprint across Europe.
• Clinica Baviera: Leading Spanish ophthalmology clinic chain (part of the Baviera group) offering refractive surgery, cataract, glaucoma, and retinal care — direct peer given Veonet's Spanish footprint via the Miranza acquisition.
• Optical Express: Pan-European ophthalmology and refractive surgery provider operating high-volume clinics offering cataract surgery, lens replacement, and laser eye treatments — closely comparable retail-style clinic model and consumer-direct GTM.
• Groupe Point Vision: French ophthalmology clinic network with 60+ centers providing cataract, glaucoma, and refractive surgery — direct European peer with similar multi-site, high-volume surgical ophthalmology model.
• Optegra: UK-headquartered ophthalmology hospital group operating dedicated eye care clinics across multiple countries, offering cataract surgery, laser vision correction, and retinal treatments — directly comparable service mix and multi-site clinic model to Veonet.
• Centre for Sight: UK private ophthalmology provider specializing in cataract, corneal, and refractive surgery with multiple clinic locations — comparable specialist eye-care clinic operator.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/veonet-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Veonet